Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson's disease
Ya Feng, Te Liu, Xin-Qun Li, et al.
Neuroscience Letters (2014) Vol. 579, pp. 35-40
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Sleep disorders, obesity, and aging: The role of orexin
Joshua P. Nixon, Vijayakumar Mavanji, Tammy A. Butterick, et al.
Ageing Research Reviews (2014) Vol. 20, pp. 63-73
Open Access | Times Cited: 120
Chronic sleep disturbance and neural injury: links to neurodegenerative disease
Aleksandar Videnovic, Sabra M. Abbott
Nature and Science of Sleep (2016), pp. 55-55
Open Access | Times Cited: 112
Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease
Еlena V. Mitroshina, Maria O. Savyuk, Evgeni Ponimaskin, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 81
The interplay of hypoxic and mental stress: Implications for anxiety and depressive disorders
Johannes Burtscher, Martin Niedermeier, Katharina Hüfner, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 138, pp. 104718-104718
Open Access | Times Cited: 50
The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration
Еlena V. Mitroshina, Maria V. Vedunova
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4581-4581
Open Access | Times Cited: 10
Hormetic approaches to the treatment of Parkinson's disease: Perspectives and possibilities
Vittorio Calabrese, Aurelia Santoro, Angela Trovato Salinaro, et al.
Journal of Neuroscience Research (2018) Vol. 96, Iss. 10, pp. 1641-1662
Open Access | Times Cited: 72
Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function
Xuan Li, Xinxin Cui, Yajing Chen, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 68
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 63
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
SIRT3 deacetylated and increased citrate synthase activity in PD model
Xinxin Cui, Li Xuan, Su‐Yan Dong, et al.
Biochemical and Biophysical Research Communications (2017) Vol. 484, Iss. 4, pp. 767-773
Closed Access | Times Cited: 60
Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease
Meifang Liu, Yan Xue, Cui Liu, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 55
Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion
Qing Chen, Xinghui Liu, Limin Xu, et al.
Oncology Reports (2016) Vol. 35, Iss. 4, pp. 1916-1924
Open Access | Times Cited: 51
Hypoxia-Induced Signaling Activation in Neurodegenerative Diseases: Targets for New Therapeutic Strategies
Niraj Kumar Jha, Saurabh Kumar Jha, Renu Sharma, et al.
Journal of Alzheimer s Disease (2018) Vol. 62, Iss. 1, pp. 15-38
Closed Access | Times Cited: 50
Acute Methylmercury Exposure and the Hypoxia-Inducible Factor-1α Signaling Pathway under Normoxic Conditions in the Rat Brain and Astrocytes in Vitro
Jie Chang, Bobo Yang, Yun Zhou, et al.
Environmental Health Perspectives (2019) Vol. 127, Iss. 12
Open Access | Times Cited: 47
Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review
Hayder M. Al‐kuraishy, MayH Abdulhadi, NawarR Hussien, et al.
Brain Circulation (2020) Vol. 6, Iss. 2, pp. 70-70
Open Access | Times Cited: 46
Orexin-A protects against cerebral ischemia-reperfusion injury by inhibiting excessive autophagy through OX1R-mediated MAPK/ERK/mTOR pathway
Dandan Xu, Tingting Kong, Shengnan Zhang, et al.
Cellular Signalling (2020) Vol. 79, pp. 109839-109839
Open Access | Times Cited: 40
Hypoxia Signaling in Parkinson’s Disease: There Is Use in Asking “What HIF?”
Laura Lestón Pinilla, Aslihan Ugun‐Klusek, Sergio Rutella, et al.
Biology (2021) Vol. 10, Iss. 8, pp. 723-723
Open Access | Times Cited: 36
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Association Between Hypoxia‐Inducible Factor‐1α and Neurological Diseases: A Bidirectional Two‐Sample Mendelian Randomization Analysis
Jing Liang, Xiaoyan Du, Mengfei Wang, et al.
Brain and Behavior (2025) Vol. 15, Iss. 3
Open Access
Orexin/Hypocretin Activates mTOR Complex 1 (mTORC1) via an Erk/Akt-independent and Calcium-stimulated Lysosome v-ATPase Pathway
Zhiqiang Wang, Shimeng Liu, Miyo Kakizaki, et al.
Journal of Biological Chemistry (2014) Vol. 289, Iss. 46, pp. 31950-31959
Open Access | Times Cited: 46
The effect of orexin-A on motor and cognitive functions in a rat model of Parkinson’s disease
Zahra Hadadianpour, Farangis Fatehi, Fateme Ayoobi, et al.
Neurological Research (2017) Vol. 39, Iss. 9, pp. 845-851
Closed Access | Times Cited: 45
Intranasal gene delivery for treating Parkinson’s disease: overcoming the blood–brain barrier
Amirah E.-E. Aly, Barbara L. Waszczak
Expert Opinion on Drug Delivery (2015) Vol. 12, Iss. 12, pp. 1923-1941
Closed Access | Times Cited: 44
The epigenetic regulation of HIF-1α by SIRT1 in MPP + treated SH-SY5Y cells
Su‐Yan Dong, Yanjie Guo, Ya Feng, et al.
Biochemical and Biophysical Research Communications (2016) Vol. 470, Iss. 2, pp. 453-459
Open Access | Times Cited: 43
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
Laurine Becquet, Catalina Abad, Mathilde Leclercq, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top